Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Forte Biosciences (FBRX) Shares Outstanding (Weighted Average) (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Shares Outstanding (Weighted Average) for 5 consecutive years, with $5.7 million as the latest value for Q3 2020.

  • Quarterly Shares Outstanding (Weighted Average) fell 99.73% to $5.7 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Sep 2020, down 99.73% year-over-year, with the annual reading at $2.1 million for FY2019, 89.49% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2020 was $5.7 million at Forte Biosciences, up from $3.7 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $2.1 billion in Q1 2020, with the low at $2.1 million in Q4 2019.
  • Average Shares Outstanding (Weighted Average) over 5 years is $342.2 million, with a median of $14.6 million recorded in 2017.
  • The sharpest move saw Shares Outstanding (Weighted Average) surged 10482.41% in 2019, then tumbled 99.83% in 2020.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $2.2 million in 2016, then skyrocketed by 563.99% to $14.6 million in 2017, then soared by 37.32% to $20.1 million in 2018, then plummeted by 89.49% to $2.1 million in 2019, then soared by 169.97% to $5.7 million in 2020.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $5.7 million, $3.7 million, and $2.1 billion for Q3 2020, Q2 2020, and Q1 2020 respectively.